BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32241691)

  • 1. Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer.
    Eichenauer T; Simmendinger L; Kluth M; Chirico V; Luebke AM; Höflmayer D; Hinsch A; Jacobsen F; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Tsourlakis MC; Büscheck F; Bernreuther C; Clauditz T; Lebok P; Simon R; Sauter G; Wilczak W; Fraune C
    Urol Oncol; 2020 Jun; 38(6):605.e1-605.e8. PubMed ID: 32241691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival.
    Eichenauer T; Bannenberg DC; Kluth M; Wittmer C; Büscheck F; Möller K; Dum D; Fraune C; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Tsourlakis MC; Bernreuther C; Minner S; Simon R; Sauter G; Wilczak W; Clauditz TS
    Urol Oncol; 2020 Feb; 38(2):43.e13-43.e20. PubMed ID: 31757738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.
    Eichenauer T; Shadanpour N; Kluth M; Göbel C; Weidemann S; Fraune C; Büscheck F; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Burandt E; Bernreuther C; Minner S; Simon R; Sauter G; Wilczak W; Clauditz T
    World J Surg Oncol; 2020 Jun; 18(1):128. PubMed ID: 32534597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma.
    de Oliveira D; Dall'Oglio MF; Reis ST; Zerati M; Souza IC; Leite KR; Srougi M
    Urol Oncol; 2014 Jul; 32(5):601-6. PubMed ID: 24629495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma.
    La Rochelle J; Klatte T; Dastane A; Rao N; Seligson D; Said J; Shuch B; Zomorodian N; Kabbinavar F; Belldegrun A; Pantuck AJ
    Cancer; 2010 Oct; 116(20):4696-702. PubMed ID: 20629029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
    El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
    Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
    El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
    Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between chromosome 9p21 locus deletion and prognosis in clinically localized prostate cancer.
    Barros ÉAF; Pontes-Junior J; Reis ST; Lima AER; Souza IC; Salgueiro JL; Fontes D; Dellê H; Coelho RF; Viana NI; Leite KRM; Nahas WC; Srougi M
    Int J Biol Markers; 2017 May; 32(2):e248-e254. PubMed ID: 28058701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma.
    Brunelli M; Eccher A; Gobbo S; Ficarra V; Novara G; Cossu-Rocca P; Bonetti F; Menestrina F; Cheng L; Eble JN; Martignoni G
    Mod Pathol; 2008 Jan; 21(1):1-6. PubMed ID: 17906617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.
    Schraml P; Struckmann K; Bednar R; Fu W; Gasser T; Wilber K; Kononen J; Sauter G; Mihatsch MJ; Moch H
    Am J Pathol; 2001 Feb; 158(2):593-601. PubMed ID: 11159196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma.
    Schraml P; Müller D; Bednar R; Gasser T; Sauter G; Mihatsch MJ; Moch H
    J Pathol; 2000 Mar; 190(4):457-61. PubMed ID: 10699995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.
    Lebok P; Roming M; Kluth M; Koop C; Özden C; Taskin B; Hussein K; Lebeau A; Witzel I; Wölber L; Geist S; Paluchowski P; Wilke C; Heilenkötter U; Müller V; Schmalfeldt B; Simon R; Sauter G; Terracciano L; Krech RH; von der Assen A; Burandt E
    Oncotarget; 2016 Dec; 7(49):81322-81331. PubMed ID: 27835607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8p deletion is strongly linked to poor prognosis in breast cancer.
    Lebok P; Mittenzwei A; Kluth M; Özden C; Taskin B; Hussein K; Möller K; Hartmann A; Lebeau A; Witzel I; Mahner S; Wölber L; Jänicke F; Geist S; Paluchowski P; Wilke C; Heilenkötter U; Simon R; Sauter G; Terracciano L; Krech R; von der Assen A; Müller V; Burandt E
    Cancer Biol Ther; 2015; 16(7):1080-7. PubMed ID: 25961141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of 9p21 Regulatory Hub Promotes Kidney Cancer Progression by Upregulating HOXB13.
    Baietti MF; Zhao P; Crowther J; Sewduth RN; De Troyer L; Debiec-Rychter M; Sablina AA
    Mol Cancer Res; 2021 Jun; 19(6):979-990. PubMed ID: 33619226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.
    Schullerus D; Herbers J; Chudek J; Kanamaru H; Kovacs G
    J Pathol; 1997 Oct; 183(2):151-5. PubMed ID: 9390026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-diploid DNA status is linked to poor prognosis in renal cell cancer.
    Büscheck F; Fraune C; Kluth M; Lennartz M; Simon R; Hube-Magg C; Morlock C; Barbieri S; Wahl C; Eichelberg C; Möller-Koop C; Höflmayer D; Wittmer C; Wilczak W; Sauter G; Fisch M; Eichenauer T; Rink M
    World J Urol; 2021 Mar; 39(3):829-837. PubMed ID: 32361874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resection.
    El-Mokadem I; Lim A; Kidd T; Garret K; Pratt N; Batty D; Fleming S; Nabi G
    BMC Cancer; 2016 Jul; 16():546. PubMed ID: 27465101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma.
    Nejati R; Wei S; Uzzo RG; Poureghbali S; Pei J; Talarchek JN; Ruth K; Dulaimi E; Kutikov A; Testa JR; Al-Saleem T
    Clin Genitourin Cancer; 2020 Feb; 18(1):56-61. PubMed ID: 31648964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.